About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
90 library items
in Cancer: pancreas
Filter results by:
Date Published
2012 (2)
2011 (12)
2010 (14)
2009 (15)
2008 (16)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: pancreas (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 90
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
|
Next
1.
London Cancer New Drugs Group Rapid Review: Folfirinox for first line treatment of advanced pancreatic cancer
Source:
London Cancer New Drugs Group
,
Date published:
07/02/2012
Category:
8.1 Cytotoxic drugs
|
8.1.3 Antimetabolites
|
8.1.5 Other antineoplastic drugs
|
Cancer: pancreas
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Folfirinox_review
2.
Case-control study looks at associations between diabetes medicines and pancreatic cancer risk
Source:
American Journal of Gastroenterology
,
Date published:
01/02/2012
Category:
6.1 Drugs used in diabetes
|
Adverse Drug Reactions
|
Cancer: pancreas
|
Diabetes
NeLM
Area:
News
Abstract
3.
AWMSG issues Final Appraisal Recommendation on sunitinib (Sutent®) for pancreatic neuroendocrine tumours
Source:
All Wales Medicines Strategy Group (AWMSG)
,
Date published:
13/10/2011
Category:
8.1.5 Other antineoplastic drugs
|
All Wales Medicines Strategy Group (AWMSG)
|
Cancer: pancreas
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
4.
Addition of radiotherapy to gemcitabine improves overall survival in unresectable pancreatic cancer?
Source:
JCO
,
Date published:
04/10/2011
Category:
8.1.3 Antimetabolites
|
Cancer: pancreas
NeLM
Area:
News
Link (abstract)
5.
Pancreatic cancer UK publishes treatment and survival report on patients with the condition
Source:
BBC Health News
,
Date published:
07/09/2011
Category:
Cancer: pancreas
NeLM
Area:
News
BBC link
Link to full report
6.
European CHMP adopts positive opinion on application for license extension of everolimus (Afinitor) to include treatment of pancreatic neuroendocrine tumours
Source:
European Medicines Agency (EMA)
,
Date published:
25/07/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: pancreas
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Licence extension
NeLM
Area:
News
Press release
Link to Opinion
7.
Lancet seminar: Pancreatic cancer
Source:
Lancet
,
Date published:
27/05/2011
Category:
Cancer: pancreas
NeLM
Area:
News
Abstract
8.
FOLFIRINOX regimen modestly improves survival in pancreatic cancer vs. gemcitabine
Source:
N Engl J Med
,
Date published:
12/05/2011
Category:
8.1 Cytotoxic drugs
|
8.1.3 Antimetabolites
|
Cancer: pancreas
NeLM
Area:
News
Link to full text; abstract presented to non-subscribers
9.
Everolimus (Afinitor®) approved in US for treatment of progressive neuroendocrine tumours of pancreatic origin
Source:
BioSpace
,
Date published:
09/05/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: pancreas
|
Food &Drug Administration (FDA)
|
New drugs
NeLM
Area:
News
BioSpace abstract
Abstract RADIANT-3 study
10.
SMC accepts use of sunitinib (Sutent®) for treatment of pancreatic neuroendocrine tumours within NHS Scotland
Source:
Scottish Medicines Consortium (SMC)
,
Date published:
09/05/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: pancreas
|
Drug reviews
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
Results 1 - 10 of 90
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
|
Next